Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance

• Giulia Adriani,
• Giulia Adriani,
• Paola Cappello,
• Sara Lovisa,
• Sara Lovisa

Affiliations

Giulia Adriani

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore

Giulia Adriani

Department of Biomedical Engineering, National University of Singapore (NUS), Singapore, Singapore

Paola Cappello

Department of Molecular Biotechnology and Health Sciences, University of Turin, Torino, Italy

Sara Lovisa

Department of Biomedical Sciences, Humanitas University, Milan, Italy

Sara Lovisa

Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy